Insiders / Bhatt Padmanabh P. / Activity
Activity — Bhatt Padmanabh P.
36 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $1.71M | -34K -50.88% | 32,930 0.06% of shares | medium |
| Mar 17, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $1.38M | -28K -41.33% | 39,334 0.07% of shares | medium |
| Mar 17, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $1.13M | -22K -56.67% | 17,044 0.03% of shares | medium |
| Mar 17, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $896.4K | +23K +133.48% | 39,794 0.07% of shares | low |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $836.1K | +23K +133.48% | 39,794 0.07% of shares | low |
| Mar 16, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $802.1K | -16K -48.24% | 17,044 0.03% of shares | medium |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $579.6K | +18K +40.87% | 62,044 0.11% of shares | low |
| Mar 17, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $579.0K | +15K +28.82% | 67,044 0.12% of shares | low |
| Mar 17, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $450.2K | +12K +30.78% | 52,044 0.09% of shares | low |
| Mar 18, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $338.8K | -7K -28.15% | 17,456 0.03% of shares | medium |
| Mar 18, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $285.6K | +7K +42.54% | 24,294 0.04% of shares | low |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $139.7K | +5K +8.06% | 67,044 0.12% of shares | low |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Common Stock | $125.8K | +4K +10.68% | 44,044 0.08% of shares | low |
| Feb 25, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Common Stock | $32.9K | -650 -3.67% | 17,044 0.03% of shares | low |
| Feb 24, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Common Stock | $32.9K | -646 -3.78% | 16,444 0.03% of shares | low |
| Feb 24, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Common Stock | $29.8K | -581 -3.63% | 15,444 0.03% of shares | low |
| Mar 18, 2026 | Sell | SUPN Supernus Pharmaceuticals Inc Common Stock | $20.8K | -412 -2.36% | 17,044 0.03% of shares | low |
| Feb 24, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Common Stock | $18.0K | -354 -2.19% | 15,840 0.03% of shares | low |
| Feb 25, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Common Stock | $0 | +1K +7.60% | 17,694 0.03% of shares | low |
| Feb 24, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Common Stock | $0 | +1K +7.89% | 17,090 0.03% of shares | low |
| Feb 24, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Common Stock | $0 | +750 +4.86% | 16,194 0.03% of shares | low |
| Feb 24, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Common Stock | $0 | +1K +7.55% | 16,025 0.03% of shares | low |
| Mar 18, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -7K -100.00% | 0 0.00% of shares | low |
| Mar 17, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -15K -75.00% | 5,000 <0.01% of shares | low |
| Mar 17, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -12K -100.00% | 0 0.00% of shares | low |
| Mar 17, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -23K -75.83% | 7,250 0.01% of shares | low |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -5K -25.00% | 15,000 0.03% of shares | low |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -18K -100.00% | 0 0.00% of shares | low |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 16, 2026 | Exercise | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | -23K -65.00% | 12,250 0.02% of shares | low |
| Feb 25, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Restricted Stock Unit | — | -1K -50.00% | 1,250 <0.01% of shares | low |
| Feb 24, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Restricted Stock Unit | — | -1K -33.33% | 2,500 <0.01% of shares | low |
| Feb 24, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Restricted Stock Unit | — | -750 -100.00% | 0 0.00% of shares | low |
| Feb 24, 2026 | Other | SUPN Supernus Pharmaceuticals Inc Restricted Stock Unit | — | -1K -25.00% | 3,375 <0.01% of shares | low |
| Feb 18, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Restricted Stock Unit | — | +3K | 3,000 <0.01% of shares | low |
| Feb 18, 2026 | Grant | SUPN Supernus Pharmaceuticals Inc Employee Stock Option (Right to Buy) | — | +14K | 13,500 0.02% of shares | low |